$MDWD Cashflow Statement | Understand Stock

$MDWD

$12.55 +$0.49 (4.02%) Close

$MDWD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to profit and loss items:
Profit from discontinued operation
Depreciation and amortization
Share-based compensation
Revaluation of warrants accounted at fair value
Issuance expenses of warrants through profit and loss
Revaluation of liabilities in respect of IIA grants
Revaluation of liabilities in respect of TEVA
Financing income and exchange differences on lease liability
Increase (decrease) in severance pay liability, net
Other (income) expenses
Financial income, net
Unrealized foreign currency loss (gain)
Adjustments to profit and loss items, total

Changes in asset and liability items:
Decrease (increase) in trade receivables
Decrease (increase) in inventories
Decrease (increase) in other receivables
Increase (decrease) in trade payables and accrued expenses
Increase in grants received in advance
Increase (decrease) in other payables
Changes in asset and liability items, total
Net cash used in continuing operating activities
Net cash used in discontinued operating activities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Interest received
Investment in short-term bank deposits, net
Net cash provided by (used in) continuing investing activities
Net cash used in discontinued investing activities
Net cash used in investing activities

Cash flows from financing activities:
Repayment of lease liabilities
Proceeds from exercise of warrants and share options
Proceeds from exercise of pre-funded warrants
Proceeds from issuance of shares
Repayment of IIA grants
Repayment of liabilities in respect of TEVA
Net cash provided by financing activities
Exchange rate differences on cash and cash equivalent balances
Decrease in cash and cash equivalents
Decrease in cash and cash equivalents from discontinued activities
Balance of cash and cash equivalents at the beginning of the year
Balance of cash and cash equivalents at the end of the year
Supplement disclosure of non-cash transactions:
Right of use asset, net, recognized with corresponding lease liability
Exercise of RSU’s
Purchase of property and equipment with credit

Comments